IN2014MN01513A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01513A
IN2014MN01513A IN1513MUN2014A IN2014MN01513A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A IN 1513MUN2014 A IN1513MUN2014 A IN 1513MUN2014A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A
Authority
IN
India
Prior art keywords
subject
allergic
peptides
timothy grass
methods
Prior art date
Application number
Other languages
English (en)
Inventor
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Original Assignee
Jolla Inst Allergy Immunolog
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog, Alessandro Sette, Veronique Schulten, Howard Grey, Bjoern Peters, Jason Greenbaum filed Critical Jolla Inst Allergy Immunolog
Publication of IN2014MN01513A publication Critical patent/IN2014MN01513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IN1513MUN2014 2012-02-07 2013-02-07 IN2014MN01513A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
IN2014MN01513A true IN2014MN01513A (enExample) 2015-09-11

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1513MUN2014 IN2014MN01513A (enExample) 2012-02-07 2013-02-07

Country Status (13)

Country Link
US (1) US10428124B2 (enExample)
EP (1) EP2812026A4 (enExample)
JP (1) JP2015513527A (enExample)
KR (1) KR20140129124A (enExample)
CN (1) CN104203277A (enExample)
AU (1) AU2013216993C1 (enExample)
BR (1) BR112014019504A2 (enExample)
CA (1) CA2864084A1 (enExample)
EA (1) EA201491481A1 (enExample)
HK (1) HK1204929A1 (enExample)
IN (1) IN2014MN01513A (enExample)
MX (1) MX2014009285A (enExample)
WO (1) WO2013119863A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
EA201691028A1 (ru) 2013-11-20 2017-01-30 Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи Пан-иммуногены пыльцы, способы и применение для модуляции иммунного ответа
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
CN105848677B (zh) 2013-12-23 2020-01-31 爱尔开-阿贝优公司 在治疗尘螨过敏症中的肽组合及其用途
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
WO2016056596A1 (ja) * 2014-10-07 2016-04-14 日本電気株式会社 Hsp70由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
US10526388B2 (en) 2015-03-09 2020-01-07 Cytlimic Inc. Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
AU2016244570B2 (en) 2015-04-07 2020-08-27 Nec Corporation Medicine
CN109415741A (zh) * 2016-05-03 2019-03-01 Sqz生物技术公司 细胞内递送生物分子以诱导耐受性
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
KR20260017488A (ko) * 2017-04-28 2026-02-05 호유 가부시키가이샤 알레르기 항원 및 그 에피토프
JP7770314B2 (ja) * 2019-11-25 2025-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 診断及び処置のための抗原ニューロン特異的エノラーゼペプチド
CN120349374B (zh) * 2025-03-25 2025-10-10 长沙理工大学 一种米渣短肽及其在降尿酸中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
ES2384045T3 (es) * 2002-06-25 2012-06-28 Merck Patent Gmbh Secuencia de ADN y preparación recombinante del alérgeno del polen de gramíneas PHI P 4
US7731970B2 (en) 2002-08-19 2010-06-08 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
WO2006076423A2 (en) 2005-01-12 2006-07-20 Monsanto Technology, Llc Genes and uses for plant improvement
SI2244734T1 (sl) * 2008-02-01 2016-11-30 Murdoch Childrens Research Institute Postopek induciranja tolerance na alergen
EP2388268A1 (en) 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
BR112013009068A2 (pt) 2010-10-15 2016-07-19 Alk Abelló As supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno
CA2868469A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
JP2015514126A (ja) 2012-04-16 2015-05-18 アルク−アベッロ エイ/エスAlk−Abello A/S 非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド

Also Published As

Publication number Publication date
CN104203277A (zh) 2014-12-10
BR112014019504A2 (pt) 2017-06-27
AU2013216993B2 (en) 2016-09-15
HK1204929A1 (en) 2015-12-11
EP2812026A4 (en) 2016-04-27
EA201491481A1 (ru) 2014-11-28
EP2812026A1 (en) 2014-12-17
AU2013216993C1 (en) 2017-01-19
JP2015513527A (ja) 2015-05-14
CA2864084A1 (en) 2013-08-15
MX2014009285A (es) 2015-02-04
US20150023992A1 (en) 2015-01-22
US10428124B2 (en) 2019-10-01
AU2013216993A1 (en) 2014-08-21
KR20140129124A (ko) 2014-11-06
WO2013119863A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
MX2014009285A (es) Alergenos del fleo de los prados y metodos y usos para la modulacion de respuesta inmune.
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
MX2019011952A (es) Proteina anti-garp y sus usos.
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
SG194755A1 (en) Pre-fusion rsv f antigens
EA201590451A1 (ru) Способ лечения меланомы с применением вируса простого герпеса и ингибитора иммунной контрольной точки
SG11201505480SA (en) Amino acid and protein hydrolysate based formulas with a stable emulsion system
EA201790109A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
BR112013020500A8 (pt) anticorpo isolado, recombinante ou purificado
BR112016011025A2 (pt) polipeptídeos anticorpo e seus usos
BR112015013127A2 (pt) imunoterapia com agentes de ligação
MX348071B (es) Variantes de fc.
WO2011113019A3 (en) Ctla4 proteins and their uses
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
IN2014CN04498A (enExample)
EP2914256A4 (en) DISUBSTITUTED AMINO ACIDS AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP3087185A4 (en) Antibodies comprising c-terminal light chain polypeptide extensions and conjugates and methods of use thereof
BR112013018742A2 (pt) cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profilática
EP3651096C0 (en) TRANSACTION VERIFICATION METHODS AND SYSTEMS
WO2014204816A3 (en) Method for assessing protein identity and stability
PH12014502352A1 (en) Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition
GB201118201D0 (en) Novel peptides
WO2016131000A3 (en) Tolerance therapeutic for treating polypeptide induced allergy
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos